XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
  Breast
  Skin
  Blood
  Prostate
  Liver
  Colon
  Thyroid
  Endometrial
  Brain
  Therapy
  Risk Factors
  Esophageal
  Bladder
  Lung
  Rectal Cancer
  Pancreatic Cancer
  Bone Cancer
  Cervical Cancer
  Testicular Cancer
  Gastric Cancer
  Ovarian Cancer
  Nerve Tissue
  Renal Cell Carcinoma
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

International Journal of Radiation Oncology

Breast Channel
subscribe to Breast newsletter

Latest Research : Cancer : Breast

   DISCUSS   |   EMAIL   |   PRINT
Radioactive seeds might reduce the burden of treatment for women suffering from early-stage breast cancer
Jan 4, 2006, 16:15, Reviewed by: Dr. Rashmi Yadav

"The seed implants reduce the treatment to a one-time event compared to the current standard of daily treatments over many weeks. The great thing is that the patient can go home right after the procedure and live a normal life while receiving her radiation."

 
Doctors in Canada are studying the effectiveness of permanent radiation seed implants following lumpectomy as an alternative to whole or partial breast irradiation for early-stage breast cancer patients, according to a study published in the January 1, 2006, issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology. This type of radiation would cut treatment time for certain patients from several weeks to one day.

For early stage breast cancer, women often undergo a lumpectomy to remove the tumor followed by radiation therapy to kill any cancer cells that may remain. Most women undergo external beam radiation, which is given every day, Monday through Friday, for six to eight weeks. Doctors have been experimenting with ways to shorten this treatment. One technique used by a growing number of radiation oncologists involves the use of temporary radiation implants. These radiation sources are delivered through a catheter into the breast, usually twice a day for one week.

In this study, the first of its kind in the world, doctors wanted to see if it was possible to use permanent implants, like what many men receive to treat prostate cancer, to combat the cancer with only one treatment. These implants, about the size of a grain of rice, would not be removed daily like with the temporary implants. Rather, the radioactive seeds would deliver radiation to the breast area for a number of weeks until they were no longer radioactive. The advantage over the temporary implants is that the patient only has to undergo one surgical procedure to receive the radiation, versus 10 treatments over one week for temporary implants.

The current treatment standard of lumpectomy followed by external beam radiation therapy is proven to keep the cancer from returning, but 38 percent of women develop significant toxicity, which can compromise their quality of life. According to early returns from the study, which began in May 2004, 44 patients have been treated successfully with the permanent implants. So far, none have evidence of their cancer returning and acute skin irritation is six times less frequent when compared to external beam radiation.

"The main motivation was to see if we could reduce the burden of treatment for women suffering from early-stage breast cancer," said Jean-Philippe Pignol, M.D., Ph.D., lead author of the study and radiation oncologist at Sunnybrook and Women's College Health Sciences Centre in Toronto, Ontario, Canada. "The seed implants reduce the treatment to a one-time event compared to the current standard of daily treatments over many weeks. The seeds also reduce the amount of radiation the normal breast tissue receives, which lessens the chance of the patient developing problems that affect their post-cancer quality of life. The great thing is that the patient can go home right after the procedure and live a normal life while receiving her radiation."

 

- The study is published in the January 1, 2006, issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO
 

http://www.astro.org/

 
Subscribe to Breast Newsletter
E-mail Address:

 

For more information on radiation therapy for breast cancer, please visit www.rtanswers.org.

To arrange an interview with Dr. Pignol or for a copy of "First Report of a Permanent Breast PD Seed Implant as Adjuvant Radiation Treatment For Early-Stage Breast Cancer," please contact Nick Lashinsky at [email protected] or 1-800-962-7876.

ASTRO is the largest radiation oncology society in the world, with more than 8,500 members who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, biology and physics, the Society is dedicated to the advancement of the practice of radiation oncology by promoting excellence in patient care, providing opportunities for educational and professional development, promoting research and disseminating research results and representing radiation oncology in a rapidly evolving healthcare environment.




Contact: Nick Lashinsky
[email protected]
703-227-0185
American Society for Therapeutic Radiology and Oncology


Related Breast News

Breast cancer chemotherapy may deterioration in cognitive function
Elderly Breast Cancer Patients May Be Under-Diagnosed And Under-Treated
Tissue Geometry Plays Crucial Role in Breast Cell Invasion
Ethnic variations in hormone levels may cause differences in breast cancer risk
Researchers set benchmarks for screening mammography
Raloxifene Reduces Breast Cancer Risk in Postmenopausal Women at All Risk Levels
Physical activity improves survival in breast cancer patients
Pedigree assessment tool correctly identifies women with higher risk of breast cancer
MRI more accurately determines cancer spread into breast ducts
Core needle biopsy gives an accurate picture of gene expression


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us